Healthcare Predictive Analytics Market Size and Share

Healthcare Predictive Analytics Market Analysis by Mordor Intelligence
The Healthcare Predictive Analytics market size is expected to grow from USD 20.31 billion in 2025 to USD 25.87 billion in 2026 and is forecast to reach USD 86.62 billion by 2031 at 27.35% CAGR over 2026-2031.
Rapid uptake of AI-enabled clinical decision support, growing cloud infrastructure, and regulatory clarity from the United States Food and Drug Administration (FDA) anchor this expansion. Real-time data from electronic health records (EHRs), wearables, and connected medical devices supplies the raw material for increasingly accurate risk models, while payers link reimbursement to measurable outcomes. Established EHR vendors integrate native analytics to lock in existing clients, and specialist firms compete with synthetic data tools that address rare-event prediction challenges. Regional adoption varies: North America currently leads, but Asia-Pacific’s digitization programs, including national cloud-first policies, signal the next demand surge for the healthcare predictive analytics market.
Key Report Takeaways
- By application, financial data analytics held 27.35% of the healthcare predictive analytics market share in 2025; clinical data analytics is projected to expand at a 29.60% CAGR through 2031.
- By analytics type, descriptive analytics led with 50.85% revenue share in 2025, while cognitive analytics is advancing at a 36.10% CAGR to 2031.
- By component, services accounted for 47.20% of the healthcare predictive analytics market size in 2025 and will grow at a 28.90% CAGR through 2031.
- By mode of delivery, on-premise solutions commanded 60.60% share of the healthcare predictive analytics market size in 2025, whereas cloud-based deployment is rising at a 33.45% CAGR to 2031.
- By geography, North America led with 37.75% revenue share in 2025; Asia-Pacific records the highest projected CAGR at 30.95% through 2031.
Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of 2026.
Market Trends and Insights
Drivers Impact Analysis of Healthcare Predictive Analytics Market*
| Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Personalized & Evidence-Based Medicine Adoption | +6.2% | Global, with North America & EU leading implementation | Medium term (2-4 years) |
| Efficiency Pressure from Value-Based Reimbursement Models | +5.8% | North America core, expanding to APAC & Europe | Short term (≤ 2 years) |
| Need to Curb Avoidable Healthcare Expenditure | +4.1% | Global, particularly acute in high-cost markets | Long term (≥ 4 years) |
| Proliferation of IoT / Wearable Data Streams | +7.3% | APAC leading adoption, North America & EU following | Medium term (2-4 years) |
| Integration of Social-Determinant Datasets into Models | +2.9% | North America & EU focus, emerging in APAC | Long term (≥ 4 years) |
| Rapid Growth of Synthetic Data Tools for Rare-Event Prediction | +3.4% | Global, with regulatory leadership in North America | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
Personalized & Evidence-Based Medicine Adoption
Providers embed multi-omic and social-determinant inputs into risk engines, advancing precision therapies and reducing adverse events. FDA guidance issued in 2025 outlines lifecycle controls that encourage transparent, bias-mitigated algorithms.[1]U.S. Food and Drug Administration, “Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations,” fda.gov Large academic centers now allocate nearly half of AI budgets to personalized monitoring and diagnostics solutions.[2]Mayo Clinic, “Advancing AI investment for diagnostics,” mayoclinic.org Genomic-EHR integration accelerates oncology breakthroughs, and early adopters report higher patient engagement scores due to more individualized care plans.
Efficiency Pressure from Value-Based Reimbursement Models
Alternative payment arrangements reward outcome improvements and cost containment, pushing real-time risk stratification into daily workflows. CMS incentives in the United States spur rapid deployments that demonstrate double-digit operating margin gains.[3]Centers for Medicare & Medicaid Services, “Innovation Center Alternative Payment Models,” cms.gov Health systems use predictive triage to prevent unplanned admissions and coordinate post-acute services, achieving documented returns on analytics investments above 120%. Timely alerts also aid staffing optimization, reducing overtime expenses that escalated after 2022 labor shortages.
Need to Curb Avoidable Healthcare Expenditure
Analytics quantify preventable costs tied to readmissions, duplicate testing, and unmanaged chronic conditions. Regional hospitals employing AI-enabled discharge planning tools cite a 25% relative decline in 30-day readmissions and lower per-patient spend. Forecasting modules align supply inventories with surgical schedules, cutting waste and freeing capital for patient-facing initiatives. Operational dashboards help executives track savings in near real time, bolstering the business case for expanded deployments.
Proliferation of IoT / Wearable Data Streams
Continuous physiologic feeds from connected devices extend monitoring beyond clinical walls and enrich predictive models with longitudinal data. Diabetes platforms forecast glucose trends hours ahead, and cardiac risk scores trigger early outpatient interventions. Cloud scalability supports quadruple the patient load versus legacy telemetry, and federated learning techniques preserve privacy while aggregating insight across institutions.
Restraints Impact Analysis of Healthcare Predictive Analytics Market*
| Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Inadequate Enterprise-Grade Data Infrastructure | -4.7% | Global, particularly acute in smaller healthcare systems | Short term (≤ 2 years) |
| Shortage of Analytics-Savvy Healthcare Professionals | -3.2% | Global, with severe shortages in specialized roles | Medium term (2-4 years) |
| Heightened Regulatory Scrutiny Over Algorithmic Bias | -2.1% | North America & EU leading regulatory frameworks | Long term (≥ 4 years) |
| Interoperability Gaps for Unstructured & Genomics Data | -1.8% | Global, with varying standards adoption rates | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
Inadequate Enterprise-Grade Data Infrastructure
Fragmented architectures hinder dataset consolidation, with 94% of executives flagging upgrades as a top-three priority in 2024. Only 28% report high organizational data literacy, slowing model operationalization. Smaller hospitals struggle to finance cloud migrations or high-performance compute nodes critical for real-time inference, extending project timelines and limiting early clinical wins.
Shortage of Analytics-Savvy Healthcare Professionals
Demand for clinicians who can interpret machine learning outputs far outstrips supply. Public health agencies recruit data scientists to plug expertise gaps, yet training pipelines lag. Talent shortages inflate consulting bills, raising total cost of ownership for first-time buyers and heightening the risk of under-used platforms that fail to affect frontline practice.
*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.
Healthcare Predictive Analytics Market Segment Analysis
By Application:
Clinical Analytics Gains Momentum amid Financial StrongholdFinancial analytics retained 27.35% of the healthcare predictive analytics market in 2025, driven by revenue cycle optimization and fraud detection. The segment remains vital because capitated contracts penalize coding errors and denials. In parallel, the healthcare predictive analytics market size for clinical analytics is projected to climb at a 29.60% CAGR, reflecting provider intent to close outcome gaps and personalize therapy. Clinical deployments span sepsis alerts, mortality prediction, and operating-room scheduling, generating measurable improvements in patient safety and resource use.
Continued investment in synthetic data augments rare-disease modeling a tuberculosis study achieved 91% diagnostic accuracy and this capability is now bundled into wider clinical analytics suites. Population health modules aggregate claims, pharmacy, and social-determinant inputs, supporting proactive outreach. Operations and supply-chain applications add incremental value by trimming inventory carry costs and balancing surgical caseloads, rounding out a diversified demand profile that supports long-run expansion of the healthcare predictive analytics market.

By Analytics Type:
Cognitive Approaches Disrupt Descriptive DominanceDescriptive tools held 50.85% revenue share of the healthcare predictive analytics market in 2025 as organizations sought basic visibility into historical performance. Those platforms act as feeders for advanced techniques, but maturity is shifting. The healthcare predictive analytics market size attributed to cognitive analytics will expand at a 36.10% CAGR, underpinned by natural language processing that parses unstructured notes and generative AI that drafts patient summaries.
Regulatory guardrails now permit adaptive algorithms, accelerating the migration from static scorecards to agentic AI that proposes interventions. Explainability remains essential: vendors embed interpretable layers that trace variable influence, satisfying compliance teams. Prescriptive modules, still nascent, recommend medication titration or staffing changes. Peer benchmarking suggests early users cut decision cycles by one-third, favoring deeper enterprise roll-outs.
By Component:
Service-Led Implementations DominateServices captured 47.20% of healthcare predictive analytics market share in 2025 and is projected to climb at a 28.90% CAGR, a testament to the implementation complexity inside regulated clinical environments. Engagements cover data readiness audits, model development, and long-term monitoring. Consultancy-led change management speeds clinician adoption and mitigates alert fatigue. Software platforms account for the remainder, supplying model libraries, workflow APIs, and governance dashboards that standardize updates.
As more systems embrace cloud-first policies, managed services layered atop platform-as-a-service offerings gain traction. Providers appreciate consumption-based billing that aligns costs with realized value. Hardware spend remains the smallest slice yet funds accelerators for deep learning workloads and edge gateways that capture bedside device streams. This mix reinforces the service-centric trajectory of the healthcare predictive analytics market.

By Mode of Delivery:
Cloud Uptake Accelerates While On-Premise Holds MajorityOn-premise installations commanded 60.60% of revenue in 2025, reflecting legacy data-center investments and local-control preferences for protected health information. Latency-sensitive inference engines for acute-care settings also favor on-site deployment. Meanwhile, the healthcare predictive analytics market size tied to cloud solutions is forecast to rise at a 33.45% CAGR, unlocking elastic compute for compute-intensive training jobs and cross-facility data aggregation.
Hybrid architectures bridge regulatory concerns and scalability by retaining identifiable data locally while pushing anonymized derivatives to public clouds for federated modeling. Cloud-native tools shorten implementation timelines by automating provisioning and security hardening. They also support zero-downtime updates so that new evidence can refresh model parameters without interrupting clinician workflows, a critical capability in fast-moving therapeutic areas.
Geography Analysis
North America Healthcare Predictive Analytics Market
North America generated 37.75% of 2025 global revenue for the healthcare predictive analytics market, buoyed by widespread EHR penetration, CMS quality incentives, and proactive FDA oversight. Leading integrated delivery networks deploy multi-disciplinary analytics teams that span clinical, financial, and operational domains, producing validated models that feed hospital command centers. Average returns on analytics investments exceed 120%, reinforcing recurrent budgeting.
Western Europe Healthcare Predictive Analytics Market
Europe follows with well-funded national digitization plans and the European Union AI Act, which prioritizes data protection and algorithmic transparency. Germany, the United Kingdom, and France support government grants that offset start-up costs and accelerate vendor certification. Ethical review boards further insulate deployments from public trust erosion, though administratively heavy processes slow commercialization relative to US timelines.
APAC Healthcare Predictive Analytics Market
Asia-Pacific is projected to record a 30.95% CAGR through 2031, making it the growth epicenter of the healthcare predictive analytics market. National payer reforms in China, Japan, and India underwrite telehealth, cloud hosting, and AI research, catalyzing mass adoption. Public-private partnerships upgrade hospital IT estates, and regional cloud providers localize data centers to comply with sovereignty laws. Strategic roadmaps prioritize predictive analytics for disease surveillance and disaster preparedness, cementing long-term regional momentum.

Regulatory Landscape
Regulation increasingly defines what qualifies as compliant clinical decision support and how predictive models are governed across their lifecycle. In the United States, the FDA continued shaping expectations for AI-enabled software through its 2025 draft guidance on AI-enabled device software functions, emphasizing total product lifecycle controls for submissions, updates, and performance monitoring in regulated use cases. At the same time, the US health IT regime is tightening the linkage between interoperability and trustworthy AI, with HHS/ONC actions focused on how predictive decision support interventions are presented, documented, and assessed for transparency and fairness within certified health IT modules.
In Europe, the EU AI Act (Regulation (EU) 2024/1689) establishes a risk-based compliance structure that covers many healthcare AI and predictive analytics deployments, including prohibitions on certain practices such as emotion inference and biometric categorization (with narrow exceptions). With the August 2026 compliance deadline for high-risk AI obligations as an anchor, procurement and implementation are shifting toward evidence-backed governance (data quality controls, human oversight, and conformity assessment-ready documentation) rather than standalone software purchases, changing how vendors package validation, monitoring, and audit support for provider organizations.
Competitive Landscape
The healthcare predictive analytics market remains moderately fragmented as EHR incumbents, enterprise software giants, and niche start-ups pursue overlapping roadmaps. Epic Systems embeds more than 100 predictive models into its core platform, serving over 400 health systems. Oracle Health leverages its cloud portfolio to integrate analytics across clinical, financial, and supply-chain modules. Specialty firms such as SAS Institute and Health Catalyst differentiate through advanced feature engineering and visual model explainers.
Start-ups like Lucem Health and MediWhale focus on undiagnosed disease detection using cross-modality inputs, tapping venture funding to refine narrow use cases. Strategic buyers increasingly acquire point solutions to fill capability gaps and present end-to-end suites to hospital executives. FDA lifecycle guidance favors vendors with robust quality management systems, contributing to consolidation.
Technology competition centers on three vectors: inference speed, explainability, and integration. Vendors that deliver sub-second risk scoring, clinician-friendly explanations, and minimal EHR configuration rise to the top of procurement shortlists. Meanwhile, synthetic data partnerships gain prominence as firms seek differentiated training corpora that sidestep privacy hurdles and accelerate rare-event model validation. Overall, switching costs and embedded workflows raise entry barriers, encouraging multi-year platform commitments.
Healthcare Predictive Analytics Industry Leaders
Cerner Corporation
Information Builders Inc.
International Business Machines Corporation (IBM)
Oracle Corporation
Health Catalyst
- *Disclaimer: Major Players sorted in no particular order

Healthcare Predictive Analytics Market Companies Covered in this Report
- Allscripts
- Oracle
- IBM (Merative & Watson Health)
- Optum
- SAS Institute
- Health Catalyst
- MedeAnalytics
- Mckesson
- Verisk Analytics
- Cerner
- Epic Systems
- SCIO Health Analytics
- Truven Health Analytics
- AyasdiAI
- HealthEC
- Inovalon
- Information Builders
- Alteryx
- AdvancedMD
- Clarify Health
Market Opportunities and Future Outlook
Workflow-native predictive AI is moving from pilots into enterprise deployments, creating room for vendors that can embed models directly into EHR-centered care pathways while meeting governance and interoperability requirements. US hospital adoption of predictive AI reached 71% in 2024, up from 66% in 2023, reinforcing demand for services-led implementation, monitoring, and change management as organizations scale from single-model use to portfolio governance. Houston Methodist deployed the HealthLeap AI clinical screening platform across its enterprise network in June 2026 to automate inpatient screening for acute complications, and the NHS saw East Kent Hospitals University NHS Foundation Trust use the Class IIb certified MEMORI platform in July 2026 to analyze routine data for earlier infection risk recognition.
Payment and program design are also opening measurable-outcome use cases where predictive analytics can be linked to care management and utilization control. The CMS Innovation Center ACCESS Model begins July 5, 2026 and tests Outcome-Aligned Payments for technology-enabled chronic care management, providing a clearer pathway for predictive risk stratification, outreach prioritization, and longitudinal monitoring within chronic care workflows. As providers expand beyond descriptive dashboards into cognitive and predictive capabilities, demand concentrates on model explainability, bias controls, and interoperability-first architectures (including FHIR-aligned data exchange) that reduce integration friction across on-premise, cloud, and hybrid deployments.
Recent Industry Developments in Healthcare Predictive Analytics Market
- June 2026: Oracle Health announced a partnership with Theator to integrate AI-powered surgical video analytics into Oracle Health EHR workflows. The integration brings predictive and cognitive insights closer to perioperative decision-making while raising the value of EHR-native analytics connections for competing platforms.
- June 2026: Health Catalyst entered into a definitive agreement to divest its Vitalware business unit to Med-Metrix for USD 147 million in cash, with closing expected in 2026. The transaction sharpens Health Catalyst's focus on its core data, analytics, and improvement technologies and can redirect capital and management attention toward predictive analytics platform capabilities.
- June 2025: IBM and Roche introduced an AI-enabled solution supporting people with diabetes, including glucose predictions that leverage analytics to anticipate trends. The collaboration shows how life sciences and technology partnerships are productizing predictive capabilities for chronic disease management, an application area in healthcare predictive analytics.
Healthcare Predictive Analytics Market Report Scope and Research Methodology
Market Definition and Coverage
For this study, the market is defined as revenues earned from predictive analytics software and related services that help healthcare organizations anticipate clinical, operational, or financial outcomes using healthcare data.
Scope exclusions: We exclude descriptive-only reporting, generic data warehousing, and tools that do not produce forward-looking predictions.
Segments Covered in This Report
- By Application
- Clinical Data Analytics
- Financial Data Analytics
- Research Data Analytics
- Operations & Supply-Chain Management
- Other Niche Applications
- By Analytics Type
- Descriptive
- Predictive
- Prescriptive
- Cognitive
- By Component
- Software
- Services
- Hardware
- By Mode of Delivery
- On-Premise
- Cloud-Based
- Hybrid
- By Geography
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
- South America
- Brazil
- Argentina
- Rest of South America
- North America
Data Sources, Market Sizing, and Validation
Desk Research
Desk research was used to build the base structure of the model and to collect repeatable reference points for demand and digital health adoption. We reviewed public health and digital health statistics, reimbursement and policy direction, and indicators that signal how quickly analytics is being embedded into care delivery and payment workflows.
Typical sources included materials such as the World Health Organization, the OECD health statistics portal, the US CDC datasets, the US FDA digital health and software guidance pages, and the US Office of the National Coordinator for Health IT on EHR adoption and interoperability. We also used company annual reports and investor presentations, along with healthcare association publications and reputable press coverage, to understand solution positioning and pricing direction. Where needed, we supplemented this with paid subscriptions for company financials and intelligence, patent databases, and news and financials to cross-check revenue mixes and product focus. These desk research sources are illustrative, and many other public and paid references were also used for data collection, validation, and research clarification.
Primary Interviews and Surveys
Primary work was used to validate what counts as predictive analytics in real buying decisions and to check how budgets are split across software and services. We spoke with a mix of solution-side experts and user-side stakeholders, covering providers, payers, and health IT teams across major regions. This helped correct assumptions on adoption, pricing, and the deployment mix when desk research signals were not clear enough.
Distribution of primary research fieldwork respondents
| Company type | Respondent position | Region |
|---|---|---|
| Top tier: 38% | CXOs: 15% | APAC: 48% |
| Mid tier: 40% | Functional/Unit leaders: 37% | EMEA: 30% |
| Smaller Players: 22% | Managers: 48% | Americas: 22% |
Market-Sizing & Forecasting
Sizing was built using a top-down approach where the addressable analytics spend in healthcare is reconstructed and then filtered by the share that is truly predictive (based on solution capability and buyer use cases). The totals were then checked using selective bottom-up approximations, such as sampling typical annual contract values by end user type and applying them to a realistic installed base, before the numbers were adjusted.
Key inputs used in the model included EHR and interoperability readiness signals, provider and payer digitization budgets, cloud versus on-premises preference, use-case adoption (for example readmission risk, population risk scoring, fraud and abuse detection, and staffing optimization), and expected price progression as deployments scale. Where a direct volume proxy was weak in a country, gaps were handled through regional benchmarking using comparable health expenditure levels and IT maturity, followed by expert re-checks.
Forecasts were produced using scenario analysis supported by trend smoothing. We stress-tested adoption curves and pricing assumptions under faster and slower implementation cycles. Final growth paths were aligned to expert feedback on procurement timelines, regulatory pushes for data sharing, and the practical speed of workflow integration.
Data Validation & Update Cycle
Outputs were validated through triangulation across independent signals, where totals were compared against related healthcare analytics spending, disclosed digital investment priorities, and observed adoption of predictive use cases in care and payment settings. When a region or end user estimate appeared out of line, the drivers were re-opened, and respondents were re-contacted to confirm whether the variance came from pricing, deployment mix, or definition differences.
Before sign-off, the model goes through multi-step analyst reviews that check arithmetic integrity, CAGR logic, and cross-segment consistency. Reports are refreshed annually, and interim updates are made when major policy, technology, or macro events materially change adoption assumptions. Right before delivery, a final pass is completed so clients receive the latest updated view.
Mordor Intelligence's Global Healthcare Predictive Analytics Market Market Sizing Compared With Other Published Estimates
Published market sizes for healthcare predictive analytics often do not match because each publisher draws the line differently on what counts as predictive versus broader analytics. Differences also show up due to the year used for the base, how cloud services are counted, and whether pricing is projected with a conservative or aggressive ramp.
The main gap comes from whether descriptive analytics and generic data platforms are counted, where Mordor Intelligence only includes revenues tied to forward-looking predictive use cases and excludes retrospective dashboards and non-predictive data warehousing tools.
Benchmark comparison
| Source | Market Size | Gaps in Research Methodology |
|---|---|---|
| Mordor Intelligence | USD 25.87 B (2026) | |
| Industry Research Publisher A | USD 13.50 B (2024) | Uses an earlier base year and may apply a narrower revenue capture that underweights scaling from 2025 onward, which can compress the current-year total when adoption is accelerating. |
| Global Consultancy B | USD 23.01 B (2025) | Treats 2025 as the base year and can broaden the definition across healthcare analytics applications, which shifts the total depending on how integrated suites and adjacent analytics modules are classified. |
The spread in the table is mainly explained by base-year choice and by how strictly predictive analytics is separated from adjacent analytics tools. By keeping the inputs tied to observable adoption signals and applying repeatable filters for what is counted, the resulting size stays easier to reconcile across regions and end users.
Key Questions Answered in the Report
What is the current value of the healthcare predictive analytics market?
The market is valued at USD 25.87 billion in 2026 and is projected to reach USD 86.62 billion by 2031.
Which application area is growing the fastest?
Clinical data analytics is forecast to expand at a 29.60% CAGR through 2031 as providers focus on outcome improvement.
How quickly are cloud-based deployments growing?
Cloud solutions are advancing at a 33.45% CAGR because elastic compute accelerates model training and real-time inference.
Why is Asia-Pacific considered a growth epicenter?
Government-backed digitization programs and rapid AI adoption give the region a projected 30.95% CAGR through 2031.
What are the primary barriers to adoption?
Limited enterprise-grade data infrastructure and shortages of analytics-savvy clinicians constrain near-term implementation.
How are regulators influencing market growth?
FDA lifecycle guidance released in 2025 provides clarity on AI device submissions, encouraging responsible innovation.
Page last updated on:




